1970-2018. Orzechowski and Walker. Tax Burden on Tobacco. Tax burden data was obtained from the annual compendium on tobacco revenue and industry statistics, The Tax Burden on Tobacco. Data are reported on an annual basis; Data include federal and state-level information regarding taxes applied to the price of a pack of cigarettes.

1965, 1966, 1970, 1974-2015, 2017. Centers for Disease Control and Prevention (CDC). Office on Smoking and Health (OSH). Survey Questions (Tobacco Use). The QIT is a compilation of more than 7,000 historical tobacco-related survey questions from various state, national and international surveys.

1970-2018. Orzechowski and Walker. Tax Burden on Tobacco. Tax burden data was obtained from the annual compendium on tobacco revenue and industry statistics, The Tax Burden on Tobacco. Data are reported on an annual basis; Data include federal and state-level information regarding taxes applied to the price of a pack of cigarettes.

2008-2020. American Lung Association. Cessation Coverage – Medicaid Barriers to Treatments. Medicaid data compiled by the Centers for Disease Control and Prevention’s Office on Smoking and Health were obtained from the State Tobacco Cessation Coverage Database, developed and administered by the American Lung Association. Data from 2008-2012 are reported on an annual basis; beginning in 2013 data are reported on a quarterly basis. Data include state-level information on Medicaid policies that make it hard for tobacco users to access cessation treatment and discourage them from quitting. Medicaid barriers include: co-payments, prior authorization, counseling required for medications, stepped care therapy, limits on duration, annual limits, lifetime limits and other barriers such as dollar limits, limits on the number of monthly prescriptions, no provision for refills or limits on which type of provider can perform treatment.

2008-2020. American Lung Association. Cessation Coverage. Medicaid data compiled by the Centers for Disease Control and Prevention’s Office on Smoking and Health were obtained from the State Tobacco Cessation Coverage Database, developed and administered by the American Lung Association. Data from 2008-2012 are reported on an annual basis; beginning in 2013 data are reported on a quarterly basis. Data include state-level information on Medicaid coverage of approved medications by the Food and Drug Administration (FDA) for tobacco cessation treatment; types of counseling recommended by the Public Health Service (PHS) and barriers to accessing cessation treatment. Note: Section 2502 of the Patient Protection and Affordable Care Act requires all state Medicaid programs to cover all FDA-approved tobacco cessation medications as of January 1, 2014. However, states are currently in the process of modifying their coverage to come into compliance with this requirement. Data in the STATE System on Medicaid coverage of tobacco cessation medications reflect evidence of coverage that is found in documentable sources, and may not yet reflect medications covered under this requirement.

U.S. Department of Health and Human Services (HHS). Centers for Disease Control and Prevention (CDC). Healthy People 2020 Tobacco Use Objectives. Healthy People 2020. Healthy People 2020 provides a framework for action to reduce tobacco use to the point that it is no longer a public health problem for the Nation. This dataset includes information related to the Healthy People 2020 Tobacco Use objectives, operational definitions, baselines, and targets. Baseline years may vary by objective. Targets represented correspond to the year 2020.

1999-2020. National Association of Attorneys General (NAAG). Policy—Tobacco Settlement Payments. The National Association of Attorneys General (NAAG) provides Tobacco Settlement Revenue data for 46 states participating in the Master Settlement Agreement (MSA) with the four largest tobacco companies in the United States. Data are reported on an annual basis. Four states (Florida, Minnesota, Mississippi and Texas) provide the STATE System their Tobacco Settlement Revenue data independently.

1997-2018. Substance Abuse and Mental Health Services Administration (SAMHSA). Synar Reports: Youth Tobacco Sales. Policy – Youth Tobacco Sales. SAMHSA’s Synar Report on Youth Tobacco Sales presents findings on compliance of the Synar Amendment aimed at decreasing youth access to tobacco, and reviews progress in enforcing State youth tobacco access laws and in reducing the percentage of retailers selling tobacco products to minors.

1970-2018. Orzechowski and Walker. Tax Burden on Tobacco. Tax burden data was obtained from the annual compendium on tobacco revenue and industry statistics, The Tax Burden on Tobacco. Data are reported on an annual basis; Data include federal and state-level information regarding taxes applied to the price of a pack of cigarettes.

2008-2020. American Lung Association. Cessation Coverage – Medicaid Coverage of Cessation Treatments. Medicaid data compiled by the Centers for Disease Control and Prevention’s Office on Smoking and Health were obtained from the State Tobacco Cessation Coverage Database, developed and administered by the American Lung Association. Data from 2008-2012 are reported on an annual basis; beginning in 2013 data are reported on a quarterly basis. Data include state-level information on Medicaid coverage of approved medications by the Food and Drug Administration (FDA) for tobacco cessation treatment and the types of counseling recommended by the Public Health Service (PHS). Approved medications by the FDA include: Nicotine patch, Nicotine gum, Nicotine lozenge, Nicotine nasal spray, Nicotine inhaler, Bupropion (Zyban) and Varenicline (Chantix). The types of counseling recommended by the PHS are: individual counseling, group counseling and phone counseling. Data do not include phone counseling which is available in every state through quitlines.